Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.

Autor:	Hansen, Barbara C.1 bchansen@aol.com, Tigno, Xenia T.2, Bénardeau, Agnes3, Meyer, Markus3, Sebokova, Elena3, Mizrahi, Jacques3
Zdroj:	Cardiovascular Diabetology. 2011, Vol. 10 Issue 1, p7-14. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu